• de
  • en
deen

International

Berlin Chemie
  • About us
    • BERLIN-CHEMIE
    • MENARINI Group
    • Our History
    • Our Goal
    • Executive Board
    • Contact
  • Responsibility
    • Code of Conduct
    • Sustainability & social commitment
    • Code of practice for business partners
  • Press
    • News and Press Releases
    • Media library
  • Jobs & Careers
  • About us
    • BERLIN-CHEMIE
      • Manufacturing & Quality assurance
      • Business Development
    • MENARINI Group
    • Our History
    • Our Goal
    • Executive Board
    • Contact
  • Responsibility
    • Code of Conduct
    • Sustainability & social commitment
    • Code of practice for business partners
  • Press
    • News and Press Releases
    • Media library
  • Jobs & Careers
  • Home >>
  • Contact >>
  • Purchasing Terms >>
  • Quality Requirements API / EXC >>
  • Data Protection Information Notice for Healthcare Professionals >>
  • Data Protection Information Notice for Patients >>
  • Privacy >>
  • Disclaimer >>
  • Imprint >>
  • Sitemap >>
  • Change cookie settings »

News and Press Releases

Press|News and Press Releases
  • News and Press Releases
  • Media library

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in

Monday, January 30, 2023
Read more

LAST NEWS

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in

1/30/2023
Read more

Ibuprofen suspension – exemption to safeguard supply of the population

1/2/2023
Read more

Berlin becomes a transfer region for green chemistry

10/6/2022
Read more

BERLIN-CHEMIE celebrates 30 years of affiliation to the MENARINI Group

9/6/2022
Read more

Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award

7/8/2022
Read more

BERLIN-CHEMIE Menarini‘s Position in der Ukraine

5/9/2022
Read more
1234NextLast

News archive

Archive

  • Expand/Collapse 2023 (2)
    • 2023, January (2)
  • Expand/Collapse 2022 (5)
    • 2022, October (1)
    • 2022, September (1)
    • 2022, July (1)
    • 2022, May (2)
  • Expand/Collapse 2021 (3)
    • 2021, November (1)
    • 2021, October (1)
    • 2021, April (1)
  • Expand/Collapse 2020 (7)
    • 2020, November (1)
    • 2020, October (1)
    • 2020, July (1)
    • 2020, June (2)
    • 2020, May (1)
    • 2020, January (1)
  • Expand/Collapse 2019 (1)
    • 2019, September (1)
  • Expand/Collapse 2018 (5)
    • 2018, December (1)
    • 2018, October (1)
    • 2018, September (1)
    • 2018, March (2)
  • Expand/Collapse 2017 (4)
    • 2017, June (1)
    • 2017, March (2)
    • 2017, January (1)
  • Expand/Collapse 2016 (6)
    • 2016, December (2)
    • 2016, November (1)
    • 2016, October (1)
    • 2016, May (1)
    • 2016, March (1)

 

Responsibility >>

BERLIN-CHEMIE

International >>

SCROLL TO TOP Berlin Chemie
Berlin Chemie
  • Home
  • Contact
  • Privacy
  • Change cookie settings »
  • Purchasing Terms
  • Quality Requirements API / EXC
  • Imprint
  • Fair Play Menarini
  • Data Protection Information Notice for Healthcare Professionals
  • Data Protection Information Notice for Patients
  • Disclaimer
  • Sitemap

CONTACT
BERLIN-CHEMIE AG - Glienicker Weg 125 - 12489 Berlin - Germany
Tel.: +49 30 6707-0
Directons: » Contact us

© 2023 BERLIN-CHEMIE AG